Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Leukemia
|
September 14, 1999
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder
V Levy, V Ugo, A Delmer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 24, 1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients
J P Marie, Z Marjanovic, A Vekhoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis
R Bouabdallah, N Mounier, C Guettier, et al.
Virchows Archiv : an International Journal of Pathology
|
February 24, 2001
Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome
T J Molina, A Delmer, F Cymbalista, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1997
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group
C Cordonnier, R Herbrecht, J L Pico, et al.
Blood
|
February 1, 1995
Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols
C Soussain, C Patte, M Ostronoff, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma
R Somers, P Carde, J Thomas, et al.
Leukemia
|
June 1, 1993
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL)
J P Marie, J N Bastie, F Coloma, et al.
Annals of Hematology
|
February 1, 1997
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment
M Hunault, D Zhou, A Delmer, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Leukemia
|
September 14, 1999
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder
V Levy, V Ugo, A Delmer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 24, 1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients
J P Marie, Z Marjanovic, A Vekhoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis
R Bouabdallah, N Mounier, C Guettier, et al.
Virchows Archiv : an International Journal of Pathology
|
February 24, 2001
Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome
T J Molina, A Delmer, F Cymbalista, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1997
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group
C Cordonnier, R Herbrecht, J L Pico, et al.
Blood
|
February 1, 1995
Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols
C Soussain, C Patte, M Ostronoff, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma
R Somers, P Carde, J Thomas, et al.
Leukemia
|
June 1, 1993
Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL)
J P Marie, J N Bastie, F Coloma, et al.
Annals of Hematology
|
February 1, 1997
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment
M Hunault, D Zhou, A Delmer, et al.
Page
of 12